ANI PHARMACEUTICALS, INC Prepaid Expense and Other Assets, Current
ANI PHARMACEUTICALS, INC (ANIP) had Prepaid Expense and Other Assets, Current of $1.14 million as of 2014-12-31, per its 10-K filed 2016-02-23.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2016-02-23
- 2014-12-31: Prepaid Expense and Other Assets, Current $1.14M.
- 2013-03-31: Prepaid Expense and Other Assets, Current $277.87K.
- 2012-12-31: Prepaid Expense and Other Assets, Current $378.80K.
- 2012-09-30: Prepaid Expense and Other Assets, Current $534.04K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2014-12-31 | $1.14M 10-K · filed 2016-02-23 |
| 2013-03-31 | $277.87K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $378.80K 10-Q · filed 2013-05-10 |
| 2012-09-30 | $534.04K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $512.64K 10-Q · filed 2012-08-01 |
| 2012-03-31 | $716.92K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $801.15K 10-K · filed 2013-02-28 |
| 2011-09-30 | $943.71K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.01M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $2.47M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |